PECCE, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 1.453
EU - Europa 713
AS - Asia 324
SA - Sud America 16
AF - Africa 9
Totale 2.515
Nazione #
US - Stati Uniti d'America 1.440
IT - Italia 393
SE - Svezia 147
SG - Singapore 144
IN - India 80
CN - Cina 61
DE - Germania 47
FI - Finlandia 31
BG - Bulgaria 17
RU - Federazione Russa 16
ID - Indonesia 15
BE - Belgio 10
GB - Regno Unito 10
CA - Canada 9
IE - Irlanda 8
KR - Corea 8
TG - Togo 8
RO - Romania 7
AR - Argentina 6
EC - Ecuador 6
FR - Francia 6
NL - Olanda 6
UA - Ucraina 6
IQ - Iraq 5
IR - Iran 5
BR - Brasile 4
CH - Svizzera 3
HK - Hong Kong 3
JP - Giappone 3
MX - Messico 3
DK - Danimarca 2
LT - Lituania 2
AT - Austria 1
CR - Costa Rica 1
HU - Ungheria 1
MA - Marocco 1
Totale 2.515
Città #
Fairfield 215
Rome 176
Chandler 120
Ashburn 112
Singapore 106
Woodbridge 91
Seattle 84
Houston 75
Wilmington 66
Cambridge 55
Santa Clara 54
Ann Arbor 38
Princeton 36
Dearborn 35
Beijing 34
San Paolo di Civitate 26
San Diego 25
Lawrence 23
Boston 21
Helsinki 18
Millbury 18
Plano 17
Sofia 17
Fremont 15
Jakarta 15
Boardman 12
Bologna 10
Milan 10
New York 10
Phoenix 9
Andover 8
Brussels 8
Dublin 8
Lomé 8
Carraia Nord 7
Legnano 7
Tivoli 7
Bremen 6
Falls Church 6
Guayaquil 6
Norwalk 6
Falkenstein 5
Grafing 5
Leawood 5
London 5
Monterotondo 5
Ottawa 5
Cagliari 4
Des Moines 4
Federal 4
Moscow 4
Naples 4
Toronto 4
Augusta 3
Basrah 3
Bern 3
Central 3
Frankfurt am Main 3
Mannheim 3
Nanjing 3
Piazza 3
Redwood City 3
Stockholm 3
Taranto 3
Bristol 2
Buenos Aires 2
Capaccio 2
Catania 2
Catanzaro 2
Cercola 2
Chengdu 2
Dallas 2
Erbil 2
Fort Worth 2
Gunzenhausen 2
Hangzhou 2
Henderson 2
Hyderabad 2
Jinan 2
Kunming 2
La Mirada 2
Lappeenranta 2
Latina 2
Laurel 2
Munich 2
Nanchang 2
Nerviano 2
Niigata 2
Noci 2
Osasco 2
Palermo 2
Philadelphia 2
Potenza 2
Sacramento 2
San Vito sullo Ionio 2
Sperone 2
Torino 2
Waanrode 2
Amsterdam 1
Ancona 1
Totale 1.777
Nome #
Identification of thyroid-associated serum microRNA profiles and their potential use in thyroid cancer follow-up 112
Analytical validation of a novel targeted next-generation sequencing assay for mutation detection in thyroid nodule aspirates and tissue 101
Correction to. Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma 98
In silico drug repurposing in COVID-19. A network-based analysis 95
MicroRNA-based molecular classification of papillary thyroid carcinoma 94
Exploring the molecular insights of concurrent composite mucoepidermoid carcinoma and papillary thyroid carcinoma 94
Molecular profiles of cancer stem-like cell populations in aggressive thyroid cancers 91
The Arabidopsis COP9 SIGNALOSOME INTERACTING F-BOX KELCH 1 Protein Forms an SCF Ubiquitin Ligase and Regulates Hypocotyl Elongation 91
Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression 89
Fibronectin-1 expression is increased in aggressive thyroid cancer and favors the migration and invasion of cancer cells 84
BRAF V600E -mutant cancers display a variety of networks by SWIM analysis: prediction of vemurafenib clinical response 82
A synonymous RET substitution enhances the oncogenic effect of an in-cis missense mutation by increasing constitutive splicing efficiency 81
Overexpression of genes involved in miRNA biogenesis in medullary thyroid carcinomas with RET mutation 78
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells 78
Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancer 75
RET mutation and increased angiogenesis in medullary thyroid carcinomas 71
A novel nonsense EIF1AX mutation identified in a thyroid nodule histologically diagnosed as oncocytic carcinoma 70
Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer 69
Expression of Leptin Receptor and Effects of Leptin on Papillary Thyroid Carcinoma Cells 68
Loss of function SETD2 mutations in poorly differentiated metastases from two Hürthle cell carcinomas of the thyroid 68
Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodules 66
Human telomerase reverse transcriptase in papillary thyroid cancer: gene expression, effects of silencing and regulation by BET inhibitors in thyroid cancer cells 64
Circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients 63
A novel double mutation val648ile and val804leu or ret proto-oncogene in multiple endocrine neoplasia type 2 62
The role of FOSL1 in stem-like cell reprogramming processes 58
The interplay between angiopoietin-like proteins and adipose tissue: Another piece of the relationship between adiposopathy and cardiometabolic diseases? 57
The Fibrinogen-like Domain of ANGPTL3 Facilitates Lipolysis in 3T3-L1 Cells by Activating the Intracellular Erk Pathway 55
Molecular mechanisms of the tyrosine kinase inhibitor pralsetinib activity in in-vitro models of medullary thyroid carcinoma: Aberrant activation of the HH-Gli signaling pathway in acquired resistance 47
Contemporary thyroid nodule evaluation and management 46
Prediction of response to vemurafenib in BRAF V600E mutant cancers based on a network approach 45
Long-term disease recurrence in the adipose tissue and striated muscles of a minimally invasive papillary thyroid carcinoma 44
The role of microRNAs in thyroid carcinomas 41
Establishment and maintenance of thyroid organoids from human cancer cells 40
The COVID-19 outbreak and de-escalation of thyroid cancer diagnosis and treatment 35
The legacy of the COVID-19 pandemics for thyroid cancer patients: towards the application of clinical practice recommendations 32
The role of miR-139-5p in radioiodine-resistant thyroid cancer 32
Rare germline variants in DNA repair-related genes are accountable for papillary thyroid cancer susceptibility 30
Identification of Exosomal microRNAs and Their Targets in Papillary Thyroid Cancer Cells 28
Randomized-comparison study on dissection of the central compartment of the neck and no surgical dissection in patients with initial thyroid cancer, negative pre-operative neck lymph-node diagnosis and intermediate–high molecular risk 22
Management of cytologically indeterminate thyroid nodules: Primum non nocere 22
Differential effects of bariatric surgery on plasma levels of ANGPTL3 and ANGPTL4 19
Carcinoma tiroideo clinicamente iniziale: studio randomizzato sulla dissezione del compartimento centrale con linfonodi del collo clinicamente negativi e rischio molecolare intermedio-alto 13
Effects of lenvatinib on glucose, cholesterol, triglycerides and estimated cardiovascular risk in patients with advanced thyroid cancer 13
Papillary thyroid carcinoma as first and isolated neoplastic disease in a Lynch syndrome family member with a germline MLH1 mutation 12
Expression of miR-31-5p affects growth, migration and invasiveness of papillary thyroid cancer cells 11
Serum microRNA-146a-5p and microRNA-221-3p as potential clinical biomarkers for papillary thyroid carcinoma 11
Protocol for oil red O staining of low-density lipoproteins for in vivo cell treatment 10
Effective TRIAC treatment of a THRβ-mutated patient with thyroid hormone resistance 8
Precision oncology for RET-related tumors 8
null 8
MicroRNAs as Biomarkers in Thyroid Carcinoma 7
Phytochemicals in thyroid cancer: analysis of the preclinical studies 3
Quercetin improves the effects of sorafenib on growth and migration of thyroid cancer cells 2
Totale 2.703
Categoria #
all - tutte 10.303
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.303


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020253 0 0 0 0 0 0 55 48 54 53 26 17
2020/2021257 26 24 4 11 4 26 3 23 29 49 13 45
2021/2022524 8 39 41 34 66 33 4 36 39 26 110 88
2022/2023525 94 115 48 35 44 45 20 34 34 3 14 39
2023/2024331 24 45 9 26 29 50 20 22 3 39 35 29
2024/2025341 23 25 56 94 70 73 0 0 0 0 0 0
Totale 2.703